• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Financial Relationships Between Pharmaceutical Companies and Internal Medicine Societies.

作者信息

Murayama Anju, Higuchi Kenichi, Senoo Yuki

机构信息

Tohoku University School of Medicine, Sendai, Miyagi, Japan.

Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.

出版信息

JAMA Netw Open. 2024 Apr 1;7(4):e244777. doi: 10.1001/jamanetworkopen.2024.4777.

DOI:10.1001/jamanetworkopen.2024.4777
PMID:38568694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10993069/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5e/10993069/2fbd5ec082b6/jamanetwopen-e244777-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5e/10993069/2fbd5ec082b6/jamanetwopen-e244777-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d5e/10993069/2fbd5ec082b6/jamanetwopen-e244777-g001.jpg

相似文献

1
Financial Relationships Between Pharmaceutical Companies and Internal Medicine Societies.制药公司与内科协会之间的财务关系。
JAMA Netw Open. 2024 Apr 1;7(4):e244777. doi: 10.1001/jamanetworkopen.2024.4777.
2
Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020.2016 年至 2020 年期间，日本制药公司与内科亚专业学会理事会成员之间的财务利益冲突。
J Eval Clin Pract. 2023 Sep;29(6):883-886. doi: 10.1111/jep.13877. Epub 2023 Jun 7.
3
Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross-sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019.日本认证儿科血液科医生/肿瘤学家与制药公司之间财务关系的评估：2016年至2019年制药公司个人付款的横断面分析
Pediatr Blood Cancer. 2022 Oct;69(10):e29891. doi: 10.1002/pbc.29891. Epub 2022 Aug 10.
4
Characteristics and Distribution of Scholarship Donations From Pharmaceutical Companies to Japanese Healthcare Institutions in 2017: A Cross-sectional Analysis.2017年制药公司向日本医疗机构提供奖学金捐赠的特点与分布：一项横断面分析
Int J Health Policy Manag. 2023;12:7621. doi: 10.34172/ijhpm.2023.7621. Epub 2023 Aug 21.
5
Cross-sectional analysis of financial relationships between board certified allergists and the pharmaceutical industry in Japan.日本认证过敏专家与制药行业之间财务关系的横断面分析。
BMC Med Ethics. 2024 Feb 20;25(1):22. doi: 10.1186/s12910-024-01014-2.
6
Financial Relationships Between Pharmaceutical Companies and Rheumatologists in Japan Between 2016 and 2019.2016 年至 2019 年期间日本制药公司与风湿病学家之间的财务关系。
J Clin Rheumatol. 2023 Apr 1;29(3):118-125. doi: 10.1097/RHU.0000000000001922. Epub 2022 Dec 7.
7
Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan.日本缬沙坦丑闻涉事作者从制药公司收到的款项。
JAMA Netw Open. 2019 May 3;2(5):e193817. doi: 10.1001/jamanetworkopen.2019.3817.
8
Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.评价日本肿瘤临床实践指南作者的制药公司支付情况和利益冲突披露
JAMA Netw Open. 2019 Apr 5;2(4):e192834. doi: 10.1001/jamanetworkopen.2019.2834.
9
Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019.医药企业向日本传染病专家支付情况：92 家药企 2016-2019 年四年间支付情况回顾性分析。
Int J Environ Res Public Health. 2022 Jun 16;19(12):7417. doi: 10.3390/ijerph19127417.
10
Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019.2016 年至 2019 年期间，日本制药公司向呼吸科医生支付的个人报酬的性质和趋势。
Respiration. 2022;101(12):1088-1098. doi: 10.1159/000526576. Epub 2022 Nov 9.

引用本文的文献

1
Cross-Sectional Analysis of Research and Non-Research Payments From the Medical Device Industry to Healthcare Professionals and Organisations in Japan in 2022.2022年日本医疗器械行业向医疗保健专业人员和组织支付研究与非研究款项的横断面分析
J Eval Clin Pract. 2025 Mar;31(2):e70066. doi: 10.1111/jep.70066.
2
Pharmaceutical industry payments to healthcare professional organisations in the United Kingdom: a seven-year cross-sectional analysis of the Disclosure UK database from 2015 to 2021.英国制药行业向医疗专业组织的付款：对2015年至2021年英国披露数据库的七年横断面分析。
J R Soc Med. 2025 Jan;118(1):16-25. doi: 10.1177/01410768241297441. Epub 2024 Nov 18.
3

本文引用的文献

1
Medical royal colleges receive millions from drug and medical devices companies.医学皇家学院从制药和医疗器械公司获得数百万资金。
BMJ. 2023 Jul 26;382:1658. doi: 10.1136/bmj.p1658.
2
Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020.2016 年至 2020 年期间，日本制药公司与内科亚专业学会理事会成员之间的财务利益冲突。
J Eval Clin Pract. 2023 Sep;29(6):883-886. doi: 10.1111/jep.13877. Epub 2023 Jun 7.
3
Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review.
Non-research payments to board-certified cardiologists from pharmaceutical industry in Japan from 2016 to 2019: a retrospective analysis.
2016年至2019年日本制药行业向获得董事会认证的心脏病专家支付的非研究款项：一项回顾性分析。
BMJ Open. 2024 Jul 31;14(7):e083445. doi: 10.1136/bmjopen-2023-083445.
4
Conflicts of Interest Among Cardiology Clinical Practice Guideline Authors in Japan.日本心脏病学临床实践指南作者的利益冲突。
J Am Heart Assoc. 2024 Apr 16;13(8):e034506. doi: 10.1161/JAHA.124.034506. Epub 2024 Apr 12.
利益冲突与临床指南、顾问委员会报告、观点文章和叙述性评论中的有利推荐之间的关联：系统评价。
BMJ. 2020 Dec 9;371:m4234. doi: 10.1136/bmj.m4234.
4
Pathways to independence: towards producing and using trustworthy evidence.通向独立之路：迈向生成和使用可靠证据
BMJ. 2019 Dec 3;367:l6576. doi: 10.1136/bmj.l6576.